RT30 30mg*10vials

Retatrutide RT30 30mg*10vials

Retatrutide is a triple-receptor agonist peptide that simultaneously activates GLP-1, GIP, and glucagon receptors, representing a high-specification metabolic research compound.

The 30mg single-vial specification provides a substantial active ingredient load per vial, making it well-suited for ultra-long-term large animal studies, high-dose gradient control experiments, and large-scale multi-group parallel research. The higher concentration reduces the frequency of vial openings and dilution steps, minimizing experimental error and sample contamination risk.

Dual GLP-1 and GIP pathway activation supports research into insulin sensitivity, glycemic regulation, and appetite-related signaling mechanisms. The glucagon receptor component adds energy expenditure and lipid metabolism pathways to the metabolic research scope.

This product is supplied as sterile lyophilized powder in glass vials, formulated for reconstitution with bacteriostatic water. Each batch undergoes comprehensive purity testing, with a certificate of analysis included.

10 vials per pack, designed for advanced preclinical research and large-scale laboratory projects.